The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Jun 2021
Historique:
received: 05 05 2021
revised: 17 06 2021
accepted: 17 06 2021
entrez: 2 7 2021
pubmed: 3 7 2021
medline: 3 8 2021
Statut: epublish

Résumé

Nonalcoholic fatty liver disease (NAFLD) is strongly associated to the features of metabolic syndrome which can progress to cirrhosis, liver failure and hepatocellular carcinoma. However, the most common cause of mortality in people with NAFLD is not liver-related but stems from atherosclerotic cardiovascular disease (CVD). The prevalence of NAFLD is on the rise, mainly as a consequence of its close association with two major worldwide epidemics, obesity and type 2 diabetes (T2D). The exact pathogenesis of NAFLD and especially the mechanisms leading to disease progression and CVD have not been completely elucidated. Human fetuin-A (alpha-2-Heremans Schmid glycoprotein), a glycoprotein produced by the liver and abundantly secreted into the circulation appears to play a role in insulin resistance, metabolic syndrome and inflammation. This review discusses the links between NAFLD and CVD by specifically focusing on fetuin-A's function in the pathogenesis of NAFLD and atherosclerotic CVD.

Identifiants

pubmed: 34205674
pii: ijms22126627
doi: 10.3390/ijms22126627
pmc: PMC8234007
pii:
doi:

Substances chimiques

alpha-2-HS-Glycoprotein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Endocrinol (Oxf). 2013 May;78(5):712-7
pubmed: 22676641
Oncotarget. 2017 Nov 10;8(63):107149-107156
pubmed: 29291018
Clin Endocrinol (Oxf). 2011 Oct;75(4):450-5
pubmed: 21521338
J Am Coll Cardiol. 2012 May 8;59(19):1688-96
pubmed: 22554599
Circulation. 2008 Dec 9;118(24):2555-62
pubmed: 19029462
Clin Sci (Lond). 2013 Oct;125(8):391-400
pubmed: 23627434
Int J Mol Sci. 2020 Aug 16;21(16):
pubmed: 32824337
Dig Dis Sci. 2013 Oct;58(10):3017-23
pubmed: 23775317
Int J Obes (Lond). 2015 May;39(5):734-41
pubmed: 25468829
Diabetes Care. 2006 Apr;29(4):853-7
pubmed: 16567827
Clin Gastroenterol Hepatol. 2015 Apr;13(4):643-54.e1-9; quiz e39-40
pubmed: 24768810
Hepatology. 2014 Jun;59(6):2178-87
pubmed: 24777953
J Clin Endocrinol Metab. 2010 Nov;95(11):4877-81
pubmed: 20660040
Nutr Metab Cardiovasc Dis. 2018 Jan;28(1):71-76
pubmed: 29122442
Hepatology. 2014 Mar;59(3):1174-97
pubmed: 24002776
Diabet Med. 2006 Apr;23(4):403-9
pubmed: 16620269
Front Endocrinol (Lausanne). 2014 Oct 27;5:164
pubmed: 25386164
Eur J Endocrinol. 2012 Mar;166(3):503-10
pubmed: 22170794
Atherosclerosis. 2016 May;248:224-9
pubmed: 27038419
Diabetes Metab Res Rev. 2009 Jul;25(5):427-34
pubmed: 19405044
Metab Syndr Relat Disord. 2013 Aug;11(4):289-95
pubmed: 23600632
Medicine (Baltimore). 2015 Sep;94(39):e1517
pubmed: 26426614
Diabetes. 2005 Dec;54(12):3541-6
pubmed: 16306373
J Endocr Soc. 2019 Aug 21;3(11):2051-2063
pubmed: 31637346
Nephron Clin Pract. 2008;108(3):c233-40
pubmed: 18334823
J Clin Endocrinol Metab. 2008 Nov;93(11):4479-85
pubmed: 18728159
Hepatology. 2016 Jul;64(1):73-84
pubmed: 26707365
PLoS One. 2020 Feb 19;15(2):e0228503
pubmed: 32074120
Diabetologia. 2016 Jun;59(6):1148-9
pubmed: 27053233
Biochem J. 2001 Jul 15;357(Pt 2):437-45
pubmed: 11439093
Electrophoresis. 1996 Mar;17(3):529-32
pubmed: 8740174
Am J Gastroenterol. 2009 Apr;104(4):861-7
pubmed: 19293782
Biomarkers. 2013 Mar;18(2):160-4
pubmed: 23410047
Diseases. 2018 Feb 16;6(1):
pubmed: 29462898
Hepatology. 2018 Jan;67(1):328-357
pubmed: 28714183
Ann Clin Biochem. 2010 Nov;47(Pt 6):549-53
pubmed: 20926473
N Engl J Med. 2014 Sep 18;371(12):1131-41
pubmed: 25229917
Biochem Biophys Res Commun. 2013 Sep 6;438(4):660-5
pubmed: 23933250
Liver Int. 2015 Mar;35(3):925-35
pubmed: 25627311
Recent Pat Endocr Metab Immune Drug Discov. 2011 May;5(2):124-46
pubmed: 22074587
Hepatology. 2004 Dec;40(6):1387-95
pubmed: 15565570
Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E266-E273
pubmed: 29138227
Semin Nephrol. 2009 Mar;29(2):156-65
pubmed: 19371806
Kidney Int. 2005 Jun;67(6):2383-92
pubmed: 15882283
J Hepatol. 2015 Apr;62(1 Suppl):S47-64
pubmed: 25920090
Adv Clin Chem. 2019;89:79-130
pubmed: 30797472
Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398
pubmed: 30902670
Cell. 1989 Aug 25;58(4):631-40
pubmed: 2766355
J Invest Surg. 2016 Oct;29(5):266-74
pubmed: 26980291
Lancet. 2003 Mar 8;361(9360):827-33
pubmed: 12642050
Endocrinol Metab Clin North Am. 2016 Dec;45(4):765-781
pubmed: 27823604
Hepatology. 2010 Feb;51(2):595-602
pubmed: 20014114
Surg Obes Relat Dis. 2015 Jan-Feb;11(1):137-41
pubmed: 25701959
Saudi J Gastroenterol. 2015 May-Jun;21(3):139-45
pubmed: 26021772
Endocrinology. 2012 Jul;153(7):2974-84
pubmed: 22619360
J Clin Invest. 2003 Aug;112(3):357-66
pubmed: 12897203
J Clin Endocrinol Metab. 2012 Dec;97(12):4717-23
pubmed: 23066121
Clin Endocrinol (Oxf). 2007 Feb;66(2):246-50
pubmed: 17223995
Diabetes Care. 2007 Aug;30(8):2119-21
pubmed: 17519430
J Clin Endocrinol Metab. 2016 Feb;101(2):644-52
pubmed: 26672634
Nephrol Dial Transplant. 2010 Jun;25(6):1853-8
pubmed: 20075438
J Am Heart Assoc. 2014 Jun 24;3(3):e000939
pubmed: 24963103
Nat Rev Endocrinol. 2017 Sep;13(9):509-520
pubmed: 28621339
Metab Syndr Relat Disord. 2015 Sep;13(7):319-25
pubmed: 26011302
Lancet Diabetes Endocrinol. 2014 Nov;2(11):901-10
pubmed: 24731669
Am J Gastroenterol. 1990 Oct;85(10):1349-55
pubmed: 2220728
Nat Rev Endocrinol. 2013 Mar;9(3):144-52
pubmed: 23337953
Arch Med Res. 2009 Oct;40(7):571-5
pubmed: 20082871
Circulation. 2006 Apr 11;113(14):1760-7
pubmed: 16567568
Diabetes Care. 2016 Apr;39(4):632-8
pubmed: 26861926
Eur J Clin Invest. 2011 Jul;41(7):703-9
pubmed: 21226708
J Am Soc Nephrol. 2009 Jun;20(6):1264-74
pubmed: 19389852
Kidney Int. 2009 May;75(9):915-28
pubmed: 19190677
Eur J Clin Invest. 2014 Jul;44(7):627-33
pubmed: 24828988
Adv Med Sci. 2014 Mar;59(1):81-4
pubmed: 24797980
Diabetes Care. 2013 May;36(5):1222-8
pubmed: 23250801

Auteurs

Teoman Dogru (T)

Department of Gastroenterology, Balikesir University Medical School, Cagis, Balikesir 10145, Turkey.

Ali Kirik (A)

Department of Internal Medicine, Balikesir University Medical School, Cagis, Balikesir 10145, Turkey.

Hasan Gurel (H)

Department of Gastroenterology, Samsun Education and Research Hospital, University of Health Sciences, Ilkadim, Samsun 55090, Turkey.

Ali A Rizvi (AA)

Division of Endocrinology, Metabolism, and Lipids, Department of Medicine, Emory University, Atlanta, GA 30322, USA.
Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC 29208, USA.

Manfredi Rizzo (M)

Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, University of South Carolina, Columbia, SC 29208, USA.
Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90133 Palermo, Italy.

Alper Sonmez (A)

Department of Endocrinology and Metabolism, Gulhane Medical School, University of Health Sciences, Ankara 06010, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH